Detection of clinically relevant gene fusions with the HTG EdgeSeq ALKPlus Assay EU
Detection of clinically relevant gene fusions with the HTG EdgeSeq ALKPlus Assay EU
- Categories
- White Papers
Detection of clinically relevant gene fusions with the HTG EdgeSeq ALKPlus Assay EU
Hindi, N., et. al., Analysis of Expression of Immunomodulation Factors in Alveolar Soft-Part Sarcoma: A Retrospective Study from the Spanish Group for Research on Sarcoma. Poster presented at European Society for Medical Oncology (ESMO). 2017 Sept 8 - 12; Madrid, Spain.
Mian O., et al. Molecular profiling of small cell bladder cancer (SCBC) to reveal gene expression determinants of an aggressive phenotype. Poster presented at: The American Society of Clinical Oncology (ASCO), 2017 Jun; Chicago, IL
Balko J., et al. Advanced molecular characterization of severe autoimmune toxicities associated with checkpoint inhibitor therapies. Poster session presented at: The American Association for Cancer Research, 2017 Apr; Washington, DC
Suda et. al. Heterogeneity in immune biomarker expression after acquisition of resistance to EGFR kirase inhibitors: Analysis of a case with small cell lung cancer transformation; J Thorac Oncol. 2017 Jun; 1216: 1015
Howard K., et al. A Cross Comparison of Technologies for the Detection of Immune System Related Gene Expression Signatures in Clinical FFPE Samples of Metastatic Prostate Cancer Patients. Poster session presented at: The American Association of Cancer Research 2017 Apr; Washington, DC.
Reinholz M., et al. Multi-Site Reproducibility and Analytic Accuracy of the HTG EdgeSeq Immuno-Oncology Assay. Poster session presented at: The Association for Molecular Pathology (AMP) Global, 2017 Apr; Berlin, Germany.
Wang et. al. AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma. Am J Pathol. 2017 Aug 187(8):1700 2017
PMID: 28627414
Foy J. P. et al, The promising impact of molecular profiling on treatment strategies in oral cancers. J. Stomatol Oral Maxillofac Sur (2017) Sep; 118(4): 242-247. doi: 10.106/j.jormas.2017.05.004.Epub 2017 May 30.
PMID: 28576460
Download pdf 706KB
View External Link
Sharma P., et al. Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2017 Mar 18(3):312
PMID: 28131785
Page last updated May 22, 2023